Welcome to

International Conference on Immunology, Vaccine Development, and Translational Science
(ICIVDTS-2026)

A global academic platform for research, innovation, and collaboration

Organized by

International Academic Research Forum (IARF)

 
Conference Date
23rd - 24th September 2026
 
Conference Location
Venice , Italy
 
Mode of Conference
Hybrid

Conference Session Tracks

Focused research themes driving global academic dialogue and innovation

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

Goals We Support

SDG 3 SDG 3 — Good Health and Well-being
SDG 4 SDG 4 — Quality Education
SDG 9 SDG 9 — Industry, Innovation and Infrastructure
SDG 16 SDG 16 — Peace, Justice and Strong Institutions
SDG 17 SDG 17 — Partnerships for the Goals
Session Tracks
Track 01
Advancements in HIV Immunology

This track focuses on the latest discoveries in the immunological responses to HIV infection. Researchers will present findings on immune evasion mechanisms and the role of T cells in controlling viral replication.

Track 02
Innovative Vaccine Technologies Against HIV

This session will explore cutting-edge vaccine platforms and technologies aimed at eliciting robust immune responses against HIV. Discussions will include mRNA vaccines, viral vectors, and nanoparticle-based approaches.

Track 03
Translational Research in HIV Vaccine Development

This track emphasizes the translation of basic immunological research into effective HIV vaccine candidates. Presentations will highlight successful case studies and ongoing clinical trials.

Track 04
Immune Response Dynamics in HIV Infection

This session will delve into the complexities of the immune response during HIV infection, including the roles of antibodies and cellular immunity. Researchers will discuss the implications of these dynamics for vaccine design.

Track 05
Adjuvants in HIV Vaccine Formulation

This track will focus on the role of adjuvants in enhancing the immunogenicity of HIV vaccines. Presentations will cover novel adjuvant systems and their mechanisms of action in promoting immune responses.

Track 06
Immunotherapy Approaches in HIV Treatment

This session will explore the potential of immunotherapeutic strategies in the management of HIV/AIDS. Topics will include immune checkpoint inhibitors and therapeutic vaccines aimed at boosting immune control.

Track 07
Clinical Trials and Regulatory Challenges in HIV Vaccines

This track will address the design and execution of clinical trials for HIV vaccine candidates, highlighting regulatory hurdles and ethical considerations. Experts will share insights on best practices and lessons learned.

Track 08
Immune Memory and Long-Term Protection Against HIV

This session will investigate the mechanisms underlying immune memory in the context of HIV infection and vaccination. Researchers will discuss strategies to enhance durable immune responses.

Track 09
Pathogen Recognition and Immune Activation in HIV

This track will focus on the mechanisms of pathogen recognition and subsequent immune activation in HIV. Presentations will highlight the role of pattern recognition receptors and their implications for vaccine development.

Track 10
Immunogenetics of HIV Susceptibility and Resistance

This session will explore the genetic factors influencing susceptibility and resistance to HIV infection. Discussions will include the role of host genetics in shaping immune responses and vaccine efficacy.

Track 11
Future Directions in HIV Vaccine Research

This track will provide a platform for discussing emerging trends and future directions in HIV vaccine research. Experts will share their visions for innovative strategies to combat HIV/AIDS globally.